|
Carolyn J Anderson, PhD
Associate Professor of Radiology
|
Education
PhD, Inorganic Chemistry, Florida State University, Tallahassee, FL 1990BS, Chemistry, University of Wisconsin Superior, Superior, WI 1985
Research Interests
The major focus of our research is the development, evaluation and application
of radiopharmaceuticals containing metal radionuclides for diagnostic imaging
and targeted radiotherapy of cancer. We are particularly interested in 64Cu
(T1/2 = 12.7 hours), in large part because it emits ß+ particles for positron
emission tomography (PET) imaging and ß- particles for radiotherapy. The agents
we are studying are 64Cu-labeled bifunctional chelate-receptor ligand conjugates
for imaging and therapy of various types of cancer. Somatostatin is a peptide hormone of
which certain tumors have upregulated receptors. We are developing new radiolabeled
bifunctional-chelator-peptide conjugates of these receptor ligands for PET and
radiotherapy. We are also interested in understanding the in vivo metabolism
and in vitro subcellular metabolism of these agents. One aspect of these
metabolism studies is the correlation of the nature of the bifunctional
chelate and the radiometal to differences in the biodistribution of
radiometal-chelate-biomolecule conjugates. With collaborators from the
University of New Hampshire, we developed cross-bridged macrocyclic chelators
for 64Cu that form highly stable complexes in animal models in vivo. The
greater in vivo stability of 64Cu-labeled cross-bridged chelator somatostatin
conjugates impart signficantly improved uptake in tumors with more rapid
clearance from blood and liver compared to 64Cu-labeled somatostatin analogs
with less stable chelators. Another major area of research in our lab is
the development of imaging agents targeting the process of cancer metastasis.
Towards this goal we are investigating radiolabeled inhibitors of matrix
metalloproteinases and radiolabeled integrin ligands for imaging of tumors
to predict metastatic potential and radiolabeled integrin ligands for
targeting bone metastases.
Educational Interests
We are currently developing curriculum for a future Graduate Program in Imaging
Sciences through NIH Roadmap Initiative funding. Stay tuned for more information
on upcoming courses on topics in the Imaging Sciences.




